Pegylated interferon-α induced hypoferremia is associated with the immediate response to treatment in hepatitis C. (Q39396566)

11 September 2017

Pegylated interferon-α induced hypoferremia is associated with the immediate response to treatment in hepatitis C. (English)

1 reference

11 September 2017

Martina U Muckenthaler

6

object named as

Martina U Muckenthaler

1 reference

11 September 2017

John D Ryan

1

1 reference

11 September 2017

Sandro Altamura

2

1 reference

11 September 2017

Emma Devitt

3

1 reference

11 September 2017

Sarah Mullins

4

1 reference

11 September 2017

Matthew W Lawless

5

1 reference

11 September 2017

John Crowe

7

1 reference

11 September 2017

language of work or name

English

0 references

publication date

11 June 2012

1 reference

11 September 2017

1 reference

11 September 2017

56

1 reference

11 September 2017

2

1 reference

11 September 2017

492-500

1 reference

Global epidemiology of hepatitis C virus infection

11 September 2017

1 reference

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C.

21 January 2018

1 reference

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

21 January 2018

1 reference

Defective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis C

21 January 2018

1 reference

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

21 January 2018

1 reference

Early viral and peripheral blood mononuclear cell responses to pegylated interferon and ribavirin treatment: the first 24 h.

21 January 2018

1 reference

Correlates and prognostic value of the first-phase hepatitis C virus RNA kinetics during treatment.

21 January 2018

1 reference

The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and beta 2-microglobulin-deficient hepatocytes

21 January 2018

1 reference

Hepcidin expression by human monocytes in response to adhesion and pro-inflammatory cytokines

21 January 2018

1 reference

Modulation of hepatitis C virus replication by iron and hepcidin in Huh7 hepatocytes

21 January 2018

1 reference

Iron in innate immunity: starve the invaders

21 January 2018

1 reference

Fine tuning of hepcidin expression by positive and negative regulators

21 January 2018

1 reference

Hepcidin, a urinary antimicrobial peptide synthesized in the liver

21 January 2018

1 reference

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

21 January 2018

1 reference

Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry

21 January 2018

1 reference

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD.

21 January 2018

1 reference

A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells

21 January 2018

1 reference

Hepcidin messenger RNA expression in human lymphocytes

21 January 2018

1 reference

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

21 January 2018

1 reference

STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo.

21 January 2018

1 reference

Ribavirin improves early responses to peginterferon through improved interferon signaling

21 January 2018

1 reference

Genomic response to interferon-alpha in chimpanzees: implications of rapid downregulation for hepatitis C kinetics

21 January 2018

1 reference

STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation

21 January 2018

1 reference

Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein

21 January 2018

1 reference

Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C.

21 January 2018

1 reference

Viral infection and iron metabolism

21 January 2018

1 reference

Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials

21 January 2018

1 reference

Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C.

21 January 2018

1 reference

Iron and chronic viral hepatitis

21 January 2018

1 reference

Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.

21 January 2018

1 reference

Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C.

21 January 2018

1 reference

Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.

21 January 2018

1 reference

Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C

21 January 2018

1 reference

Reduced serum hepcidin levels in patients with chronic hepatitis C.

21 January 2018

1 reference

Iron enhances hepatitis C virus replication in cultured human hepatocytes

21 January 2018

1 reference

Iron regulates hepatitis C virus translation via stimulation of expression of translation initiation factor 3.

21 January 2018

1 reference

Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells

21 January 2018

1 reference

Iron in liver diseases other than hemochromatosis

21 January 2018

1 reference

Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion

21 January 2018

1 reference

Chronic hepcidin induction causes hyposideremia and alters the pattern of cellular iron accumulation in hemochromatotic mice

21 January 2018

1 reference

STAT3 complements defects in an interferon-resistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities

21 January 2018

1 reference

Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies

21 January 2018

1 reference

STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6.

21 January 2018

1 reference

Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice

21 January 2018

1 reference

Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels

21 January 2018

1 reference

7 January 2021

Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS

1 reference

7 January 2021

Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C

1 reference

7 January 2021

Measurements of iron status in patients with chronic hepatitis

1 reference

7 January 2021

Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C

1 reference

7 January 2021

beta-Thymosins are not simple actin monomer buffering proteins. Insights from overexpression studies

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.25666

1 reference

11 September 2017

1 reference